Research graph
References from Guidance on calculating doses of antineoplastic agents for transgender and gender-expansive patients taking gender-affirming hormone therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Impact of Hormone Therapy on Laboratory Values in Transgender Patients
10.1373/clinchem.2018.292730 · 2019 · External reference
The effect of gender-affirming hormone therapy on serum creatinine in transgender individuals
10.1016/j.eprac.2021.08.009 · 2022 · External reference
Prediction of creatinine clearance from serum creatinine
10.1159/000180580 · 1976 · External reference
Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation
10.1345/aph.1s176 · 2013 · External reference
Unresolved reference
External reference
Metabolic effects of hormone therapy in transgender patients
10.4158/ep15950.or · 2016 · External reference
Implications for medication dosing for transgender patients: a review of the literature and recommendations for pharmacists
10.1093/ajhp/zxz355 · 2020 · External reference
Approach to interpreting common laboratory pathology tests in transgender individuals
10.1210/clinem/dgaa546 · 2021 · External reference
Transgender man being evaluated for a kidney transplant
10.1373/clinchem.2016.268839 · 2017 · External reference
Kidney transplantation in transgender patients
10.1007/s11934-020-0953-x · 2020 · External reference
Assessment of renal function in transgender patients with kidney disease
10.1177/20543581211020168 · 2021 · External reference
Anticancer dose adjustment for patients with renal and hepatic dysfunction: from scientific evidence to clinical application
10.3390/scipharm85010008 · 2017 · External reference
The effect of gender-affirming hormone therapy on measures of kidney function: a systematic review and meta-analysis
10.2215/cjn.01890222 · 2022 · External reference
